SUPPRESSION OF ADVANCED GLYCATION AND LIPOXIDATION END PRODUCTS BY ANGIOTENSIN II TYPE-1 RECEPTOR BLOCKER CANDESARTAN IN TYPE 2 DIABETIC PATIENTS WITH ESSENTIAL HYPERTENSION
Dados Bibliográficos
AUTOR(ES) | |
---|---|
ANO | 2013 |
TIPO | Artigo |
PERIÓDICO | FUKUSHIMA JOURNAL OF MEDICAL SCIENCE |
ISSN | 0016-2590 |
E-ISSN | 2185-4610 |
EDITORA | The Fukushima Society of Medical Science |
DOI | 10.5387/fms.59.69 |
ADICIONADO EM | 2025-08-18 |
MD5 |
fa3cc0d5d59b691fae9f8162266ab992
|